Dilşad Türkdoğan

Dilşad Türkdoğan

Auto-generated profile, based on publicly available information

Dilşad Türkdoğan

Department of Pediatric Neurology, Marmara University Faculty of Medicine, Pendik Training and Research Hospital, Istanbul, Türkiye

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2019 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
YFYen-Chen Anne Feng
Yen-Chen Anne Feng
DHDaniel P. Howrigan
Daniel P. Howrigan
LALiam E. Abbott
Liam E. Abbott
KTKatherine Tashman
Katherine Tashman
FCFelecia Cerrato
Felecia Cerrato
BNBenjamin M. Neale
Benjamin M. Neale

23 May 2012 in Human Mutation
Verified
Journal Article
Closed access
PDF file
JSJulian Schubert
Julian Schubert
RPRoberta Paravidino
Roberta Paravidino
FBFelicitas Becker
Felicitas Becker
ABAndrea Berger
Andrea Berger
NBNerses Bebek
Nerses Bebek
YWYvonne G. Weber
Yvonne G. Weber
Mutations in PRRT2 have been described in paroxysmal kinesigenic dyskinesia (PKD) and infantile convulsions with choreoathetosis (PKD with infantile seizures), and recently also in some families with benign familial infantile seizures (BFIS) alone. We analyzed PRRT2 in 49 families and three sporadic cases with BFIS only of Italian, German, Turkish, and Japanese origin and identified the previously described mutation c.649dupC in an unstable series of nine cytosines to occur in 39 of our families and one sporadic case (77% of index cases). Furthermore, three novel mutations were found in three other families, whereas 17% of our index cases did not show PRRT2 mutations, including a large family with late‐onset BFIS and febrile seizures. Our study further establishes PRRT2 as the major gene for BFIS alone. Hum Mutat 33:1439–1443, 2012.

1 April 2011 in Sleep Medicine
Verified
Journal Article
Closed access
DTDilşad Turkdogan
Dilşad Turkdogan
NBNural Bekiroglu
Nural Bekiroglu
SZSennur Zaimoglu
Sennur Zaimoglu

15 March 2006 in European Journal of Human Genetics
Verified
Journal Article
Open access
PDF file
KVKaate R J Vanmolkot
Kaate R J Vanmolkot
EKEsther E Kors
Esther E Kors
UTUlku Turk
Ulku Turk
DTDylsad Turkdogan
Dylsad Turkdogan
AKAntoine Keyser
Antoine Keyser
Arn M.J.M. van den MaagdenbergArn M.J.M. van den Maagdenberg
Arn M.J.M. van den Maagdenberg
Familial hemiplegic migraine (FHM) is a rare autosomal dominantly inherited subtype of migraine, in which hemiparesis occurs during the aura. The majority of the families carry mutations in the CACNA1A gene on chromosome 19p13 (FHM1). About 20% of FHM families is linked to chromosome 1q23 (FHM2), and has mutations in the ATP1A2 gene, encoding the α2-subunit of the Na,K-ATPase. Mutation analysis in a Dutch and a Turkish family with pure FHM revealed two novel de novo missense mutations, R593W and V628M, respectively. Cellular survival assays support the hypothesis that both mutations are disease-causative. The identification of the first de novo mutations underscores beyond any doubt the involvement of the ATP1A2 gene in FHM2.

13 January 2012 in Epilepsia
Verified
Journal Article
Open access
PDF file
ECEPICURE Consortium
EPICURE Consortium
CLCostin Leu
Costin Leu
CKCarolien G.F. de Kovel
Carolien G.F. de Kovel
FZFederico Zara
Federico Zara
PSPasquale Striano
Pasquale Striano
TSThomas Sander
Thomas Sander
Summary: Purpose:  Genetic generalized epilepsies (GGEs) have a lifetime prevalence of 0.3% with heritability estimates of 80%. A considerable proportion of families with siblings affected by GGEs presumably display an oligogenic inheritance. The present genome‐wide linkage meta‐analysis aimed to map: (1) susceptibility loci shared by a broad spectrum of GGEs, and (2) seizure type–related genetic factors preferentially predisposing to either typical absence or myoclonic seizures, respectively.Methods:  Meta‐analysis of three genome‐wide linkage datasets was carried out in 379 GGE‐multiplex families of European ancestry including 982 relatives with GGEs. To dissect out seizure type–related susceptibility genes, two family subgroups were stratified comprising 235 families with predominantly genetic absence epilepsies (GAEs) and 118 families with an aggregation of juvenile myoclonic epilepsy (JME). To map shared and seizure type–related susceptibility loci, both nonparametric loci (NPL) and parametric linkage analyses were performed for a broad trait model (GGEs) in the entire set of GGE‐multiplex families and a narrow trait model (typical absence or myoclonic seizures) in the subgroups of JME and GAE families.Key Findings:  For the entire set of 379 GGE‐multiplex families, linkage analysis revealed six loci achieving suggestive evidence for linkage at 1p36.22, 3p14.2, 5q34, 13q12.12, 13q31.3, and 19q13.42. The linkage finding at 5q34 was consistently supported by both NPL and parametric linkage results across all three family groups. A genome‐wide significant nonparametric logarithm of odds score of 3.43 was obtained at 2q34 in 118 JME families. Significant parametric linkage to 13q31.3 was found in 235 GAE families assuming recessive inheritance (heterogeneity logarithm of odds = 5.02).Significance:  Our linkage results support an oligogenic predisposition of familial GGE syndromes. The genetic risk factor at 5q34 confers risk to a broad spectrum of familial GGE syndromes, whereas susceptibility loci at 2q34 and 13q31.3 preferentially predispose to myoclonic seizures or absence seizures, respectively. Phenotype– genotype strategies applying narrow trait definitions in phenotypic homogeneous subgroups of families improve the prospects of disentangling the genetic basis of common familial GGE syndromes.

1 August 2018 in Clinical Nutrition ESPEN
Verified
Journal Article
Closed access
KAKursad Aydin
Kursad Aydin
YAYilmaz Akbas
Yilmaz Akbas
BUBulent Unay
Bulent Unay
MAMutluay Arslan
Mutluay Arslan
ACAli Cansu
Ali Cansu
ASAysugul Alptekin Sarioglu
Aysugul Alptekin Sarioglu